The Russian Direct Investment Fund announced today, Monday, that a small clinical study of vaccination with AstraZeneca and then Sputnik Lite vaccine to prevent Covid-19 disease showed a significant growth of antibodies in the participants.
The findings were based on data from 20 people out of 100 who took part in the study, which began in Azerbaijan in February. The fund said that these participants received a dose of the AstraZeneca vaccine first, and then a dose of the Russian Sputnik Lite vaccine after 29 days.
He also added, “The results of the phased analysis showed a fourfold or more increase in neutralizing antibodies to the protein S in SARS-CoV-2 virus in 85% of the volunteers on day 57 of the study,” according to Reuters.
And ultra-small antibodies stick and bind to viruses and bacteria that invade our bodies, and this attachment to the attacking virus alerts the immune system, as if there is a red flag on the virus, allowing the rest of the immune system’s defenses to attack and eliminate the virus.
Expressive image – Antibodies
It is noteworthy that the World Health Organization, last July, described mixing several types of vaccines against the Corona virus with the “wrong direction”, explaining that it “may lead to a chaotic situation.”
Soumya Swaminathan, chief scientist at the World Health Organization, said there was “not much data available on the health impact” of combining COVID-19 vaccines produced by different companies.
“It’s a very dangerous trend. We lack data and evidence when it comes to the issue of combination vaccines,” she added during an online briefing.